Rapid Dose Therapeutics Corp

XCNQ:DOSE (Canada)  
C$ 0.18 (+5.88%) Mar 28
At Loss
Market Cap:
C$ 18.89M ($ 13.95M)
Enterprise V:
C$ 21.48M ($ 15.86M)
Volume:
39.70K
Avg Vol (2M):
27.17K
Also Trade In:
Volume:
39.70K
At Loss

Business Description

Description
Rapid Dose Therapeutics Corp is a Canadian biotechnology company revolutionizing drug delivery through innovation. The company's flagship product QuickStrip is a thin, orally dissolvable film, that can be infused with an infinite list of active ingredients (nutraceuticals, pharmaceuticals, vaccines, cannabis) that are delivered quickly into the bloodstream resulting in rapid onset of the active ingredient.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.06
Equity-to-Asset -2.28
Debt-to-Equity -0.61
Debt-to-EBITDA -1.18
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -31.41
Distress
Grey
Safe
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 70.56
9-Day RSI 60.62
14-Day RSI 56.56
6-1 Month Momentum % 63.64
12-1 Month Momentum % 100

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.13
Quick Ratio 0.1
Cash Ratio 0.04
Days Inventory 117.77
Days Sales Outstanding 28.36
Days Payable 2057.07

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -10.4
Shareholder Yield % -4.7
Name Current Vs Industry Vs History
Gross Margin % 49.76
Operating Margin % -292.82
Net Margin % -342.87
FCF Margin % -103.25
ROA % -160.7
ROIC % -103.18
ROC (Joel Greenblatt) % -179.19

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 18.89
EV-to-EBIT -7.01
EV-to-EBITDA -9.18
EV-to-Revenue 20.55
EV-to-FCF -18.94
Earnings Yield (Greenblatt) % -14.26
FCF Yield % -5.71

Financials

XCNQ:DOSE's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Rapid Dose Therapeutics Corp Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil C$) 1.045
EPS (TTM) (C$) -0.046
Beta -0.96
Volatility % 144.55
14-Day RSI 56.56
14-Day ATR (C$) 0.012807
20-Day SMA (C$) 0.164
12-1 Month Momentum % 100
52-Week Range (C$) 0.09 - 0.275
Shares Outstanding (Mil) 104.95

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Rapid Dose Therapeutics Corp Filings

Filing Date Document Date Form
No Filing Data

Rapid Dose Therapeutics Corp Stock Events

Financials Calendars
Event Date Price(C$)
No Event Data

Rapid Dose Therapeutics Corp Frequently Asked Questions

What is Rapid Dose Therapeutics Corp(XCNQ:DOSE)'s stock price today?
The current price of XCNQ:DOSE is C$0.18. The 52 week high of XCNQ:DOSE is C$0.28 and 52 week low is C$0.09.
When is next earnings date of Rapid Dose Therapeutics Corp(XCNQ:DOSE)?
The next earnings date of Rapid Dose Therapeutics Corp(XCNQ:DOSE) is .
Does Rapid Dose Therapeutics Corp(XCNQ:DOSE) pay dividends? If so, how much?
Rapid Dose Therapeutics Corp(XCNQ:DOSE) does not pay dividend.

Press Release

Subject Date
No Press Release